Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment options for large hemispheric stroke.

T Steiner1, P Ringleb, W Hacke

  • 1Department of Neurology, Heidelberg University Clinic, Heidelberg, Germany.

Neurology
|September 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Palliative neurology].

Die Anaesthesiologie·2024
Same author

[Palliative neurology].

Der Nervenarzt·2024
Same author

Quantitative analysis of the impact of infectious disease physicians on patients in the emergency department fast-track parenteral antibiotics program.

BMC infectious diseases·2024
Same author

Prior Thrombectomy Does Not Affect the Surgical Complication Rate of Decompressive Hemicraniectomy in Patients with Malignant Ischemic Stroke.

Neurocritical care·2023
Same author

Performance of commercial growing-finishing pigs fed supplemental isoquinoline alkaloids: a statistical process control analysis.

Porcine health management·2023
Same author

Identification of risk factors for postoperative delirium in patients following intraoral reconstruction with microvascular free flaps: a matched-pair analysis.

International journal of oral and maxillofacial surgery·2023
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Malignant middle cerebral artery (MCA) infarction causes severe brain swelling and high mortality. Decompression surgery and hypothermia show promise in reducing intracranial pressure and improving survival rates for stroke patients.

Area of Science:

  • Neurology
  • Neurosurgery
  • Critical Care Medicine

Background:

  • Malignant middle cerebral artery (MCA) infarction leads to severe brain edema, increased intracranial pressure (ICP), and herniation.
  • This condition has a high mortality rate (80%) with standard treatments, and survivors often experience significant disability.
  • Diagnosis can be challenging, with the condition often missed despite clear clinical and CT scan criteria.

Purpose of the Study:

  • To review current and emerging treatments for malignant MCA infarction.
  • To highlight the effectiveness of decompression surgery and hypothermia in managing elevated ICP and improving patient outcomes.

Main Methods:

  • Review of conventional treatments for reducing ICP, including osmotherapy, barbiturates, buffers, and hyperventilation.

Related Experiment Videos

  • Analysis of data from the Heidelberg decompression surgery trial.
  • Evaluation of moderate hypothermia as a therapeutic intervention.

    • Main Results:

    • Conventional ICP-reducing therapies offer only short-term relief.
    • Decompression surgery significantly reduced mortality from 76% to 32% in one trial, with 66% of survivors achieving independence.
    • Moderate hypothermia (33-36°C) reduced ICP and mortality (to 44%) when initiated within 14 hours of ischemic injury and maintained for 72 hours.

    Conclusions:

    • Malignant MCA infarction requires aggressive management beyond standard ICP-lowering therapies.
    • Decompression surgery and moderate hypothermia represent promising therapeutic strategies with the potential to significantly improve survival and functional outcomes.
    • Further research and clinical application of these advanced treatments are warranted.